Siegfried Holding AG
SFZN
株式のランク
#4106
Siegfried Holding AG, together with its subsidiaries, engages in contract... Siegfried Holding AG, together with its subsidiaries, engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide. It offers drug substances, including exclusive synthesis that manufactures custom APIs. The company also offers an API portfolio, including non-exclusive APIs and pharma-grade substances that focus on anesthetics, pain and addiction treatment applications, and central nervous and respiratory diseases, as well as caffeine for human health and nutrition. In addition, it offers drug products, including steriles, which includes fill and finish in vials, ampoules, cartridges, and pre-filled syringes; ophthalmics, such as sterile ointments, gels, and suspensions and solutions; inhalation products, including capsules in medical devices for inhalation applications; oral solid dosage forms, which includes tablets and capsules; and viral vectors, such as AAV and lentiviruses for gene therapy. Further, the company provides technologies with chemistry capabilities, analytical services, formulation technologies, bridging technologies, containment technology, and cell and gene therapies. The company was founded in 1873 and is headquartered in Zofingen, Switzerland.
株価
$88.34
時価総額
$3.87B
変化（1日）
1.68%
変化（1年）
-12.97%
国
CH
取引 Siegfried Holding AG (SFZN)
カテゴリー
Healthcare
Siegfried Holding AG（SFZN）のEPS
2026 時点のEPS TTM: 0
Siegfried Holding AGの最新の財務報告と株価によると、同社の現在のEPS（TTM）は0です。2026年末には、EPSは0で、2026年のEPS0と同等でした。
Siegfried Holding AGのEPS履歴（2002から2026まで）
各年末時点のEPS
| 年 | EPS | 変化 |
|---|---|---|
| 2025 | $4.85 | 18.12% |
| 2024 | $4.11 | -87.02% |
| 2023 | $31.64 | -21.09% |
| 2022 | $40.10 | 60.83% |
| 2021 | $24.93 | 52.56% |
| 2020 | $16.34 | 23.03% |
| 2019 | $13.28 | -3.35% |
| 2018 | $13.74 | 30.30% |
| 2017 | $10.55 | 49.52% |
| 2016 | $7.05 | -28.70% |
| 2015 | $9.89 | -1.42% |
| 2014 | $10.04 | -40.57% |
| 2013 | $16.89 | 168.36% |
| 2012 | $6.29 | 123.93% |
| 2011 | $2.81 | -154.60% |
| 2010 | $-5.15 | -58.42% |
| 2009 | $-12.38 | -51.03% |
| 2008 | $-25.28 | -258.81% |
| 2007 | $15.92 | 65.86% |
| 2006 | $9.60 | -4.54% |
| 2005 | $10.05 | 90.16% |
| 2004 | $5.29 | -66.53% |
| 2003 | $15.80 | 5.55% |
| 2002 | $14.96 | 0.00% |
同様の企業または競合他社のEPS
| 企業 | EPS | EPSの差 | 国 |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | - |
IN
|
